BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT03564340-completion@plaintrial.com
DTSTAMP:20261027T201733Z
DTSTART;VALUE=DATE:20270131
SUMMARY:Study of REGN4018 (Ubamatamab) Administered Alone or in Combination
  With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other 
 Recurrent Mucin-16 Expressing (MUC16+) Cancers — estimated completion da
 te
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT03564340
URL:https://plaintrial.com/trial/NCT03564340
END:VEVENT
END:VCALENDAR